An observational study to assess the usefulness of Eberconazole cream (Ebernet®) in patients with tinea (fungal) infectio
Not Applicable
Completed
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2019/05/019449
- Lead Sponsor
- Dr Reddys Laboratories Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
1. Patients of either sex, greater than and equal to 18 years of age
2. Patients prescribed eberconazole 1% cream for topical treatment of tinea cruris and tinea corporis by the treating physician.
3. Patients willing to give written informed consent for study participation.
Exclusion Criteria
1. Patients requiring systemic anti-fungal drugs for management of their condition.
2. Pregnant and lactating women.
3. Patients with any significant medical illness that would prevent study participation, at investigatorâ??s discretion.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method